Jazz Pharmaceuticals plc Stock
Jazz Pharmaceuticals plc Stock
We can see a decrease in the price for Jazz Pharmaceuticals plc. Compared to yesterday it has lost -€1.120 (-1.150%).
With 24 Buy predictions and not a single Sell prediction Jazz Pharmaceuticals plc is an absolute favorite of our community.
With a target price of 184 € there is a hugely positive potential of 89.61% for Jazz Pharmaceuticals plc compared to the current price of 97.04 €.
Pros and Cons of Jazz Pharmaceuticals plc in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Jazz Pharmaceuticals plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Jazz Pharmaceuticals plc | -1.150% | -0.736% | -4.816% | -18.998% | -13.008% | -31.806% | -17.763% |
| Opko Health Inc. | 3.200% | 3.859% | 11.712% | 0.062% | -8.968% | -57.924% | -19.278% |
| Catalent Inc. | 0.650% | -1.861% | -5.237% | 40.652% | 20.340% | -40.265% | 22.269% |
| Repligen Corp. | -1.020% | -5.628% | -11.376% | -11.972% | -17.959% | -5.951% | - |
Comments
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for JAZZ provided by MarketBeat